Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study

Creative Commons License

Pellanda A. F. , De Bari B., Deniaud-Alexandre E., Krengli M., Van Houtte P., Richetti A., ...Daha Fazla

CHINESE JOURNAL OF CANCER RESEARCH, cilt.29, ss.521-532, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Objective: Primary uterine leiomyosarcomas (ULMS) are rare, and the optimal treatment is controversial. We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS.